
We Win Limited Approves Grant of 250,000 Employee Stock Options Under ESOP 2025
WE WIN LIMITED has approved the grant of 2,50,000 Employee Stock Options (Options) for its eligible employees under the We Win Limited ESOP 2025 Scheme.The nomination and remuneration committee (NRC) of the Company's Board of Directors approved the grant of options during its meeting held on May 15, 2026. These options have a face value of 210/- each and were granted at a corresponding grant price of 210/- per Option.
This approval follows the shareholders passing a Special Resolution on December 19, 2025, and the Company receiving in-principle approvals from the National Stock Exchange of India Limited and BSE Limited on March 23, 2026. The options are designated for the eligible employees of the Company, as determined by the NRC.
Key Details of Stock Options Granted
The options are part of the We Win Limited ESOP 2025 Scheme and are subject to specific terms regarding vesting and exercise.| Detail | Specification |
|---|---|
| Total Options Granted | 2,50,000 (Two Lakh Fifty Thousand) |
| Face Value per Option | 210/- |
| Grant Price per Option | 210/- |
| Scheme Name | We Win Limited ESOP 2025 |
| Minimum Vesting Period | 1 year |
| Maximum Exercise Period | 3 years from the date of vesting |
Structure of the ESOP Scheme
The scheme is administered by the Nomination and Remuneration Committee of the Company. The options granted under the We Win Limited ESOP 2025 shall vest only after completing a minimum vesting period of one year. Shares resulting from the exercise of these options will be freely transferable and will not be subject to any lock-in, except as mandated by applicable laws.The grant covers a total of 2,50,000 equity shares of the company.
WEWIN Stock Price Movement
As of 11:49 AM, shares of WE WIN LIMITED are holding steady at ₹62.00 in live trading, registering 0.00% change for the day. The stock has seen a total volume of 1,832 shares traded, keeping investor attention focused on the services sector.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.